
Overview
Dr. Madhulika (Mika) Varma, chief of colorectal surgery at UCSF Medical Center, specializes in diseases of the colon, rectum and anus. Her areas of expertise include colorectal and anal cancer, inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, and pelvic floor disorders. She also is a specialist in treating many of these diseases using laparoscopic (minimally invasive) surgical techniques. Varma is director of the Center for Pelvic Physiology, which evaluates patients with fecal incontinence, constipation, rectal cancer and anal fistula. She is co-director of the UCSF Center for Inflammatory Bowel Disease and a member of the Women's Continence Center and Women's Health Clinical Research Center. Varma's research interests include clinical outcomes for inflammatory bowel diseases and defecation disorders. Varma earned her medical degree at the Warren Alpert Medical School of Brown University. She completed a residency in general surgery at UCSF and spent a year at the University of Minnesota for specialized training in colon and rectal surgery. In 2000, she returned to UCSF, where she completed a fellowship in clinical outcomes research and epidemiology.
Dr. Varma is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Crohn's Disease, Colorectal Cancer, Hernia Surgery, and Bladder Reconstruction.
Dr. Varma is board certified in American Board Of Colon And Rectal Surgery, Colon & Rectal Surgery and American Board Of Surgery, General Surgery. She is actively involved in clinical research, co-authoring 52 peer reviewed articles. Dr. Varma is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MEDICARE DISCOUNT CARD
- MEDICARE MAPD
Locations
1825 Fourth St., Fourth Floor, San Francisco, CA 94158
Additional Areas of Focus
Dr. Varma has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Center For Neuroendocrine Tumors
Dr. Emily Bergsland is a gastrointestinal oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center and the director of the UCSF Center for Neuroendocrine Tumors. She specializes in the multidisciplinary care of patients with neuroendocrine cancers. Bergsland's research is focused on better understanding why neuroendocrine tumors develop, identifying and testing new therapies, and improving outcomes in affected patients. Bergsland earned her medical degree at the University of Minnesota, then completed a residency in internal medicine and fellowship in medical oncology at UCSF. Dr. Bergsland is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Carcinoid Syndrome, Hepatectomy, and Liver Embolization. Dr. Bergsland is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Bergsland is currently accepting new patients.
Gastrointestinal Medical Oncology Clinic
Dr. Andrew H. Ko is a specialist in digestive system cancers. He provides compassionate and individualized care for patients with cancers of the pancreas, stomach and esophagus. In research, Ko has long been active in developing and evaluating new treatments for gastrointestinal cancers, including molecularly targeted agents and immune-based therapies. Ko earned an undergraduate degree in applied mathematics and biology at Brown University. He earned his medical degree at the Johns Hopkins University School of Medicine. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School, and completed a fellowship in medical oncology at Stanford University. He joined UCSF in 2001. Dr. Ko is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Stomach Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Ko is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Ko is currently accepting new patients.
Prostate Cancer Center
Dr. Maxwell Meng is a surgeon specializing in urologic cancers and laparoscopy. His interests in patient care include diagnosing and managing cancers of the genital and urinary organs, as well as minimally invasive treatments of both benign and malignant diseases. He is experienced in robotic surgery. Meng is active in research to develop new treatment technologies. Meng earned his medical degree at Johns Hopkins School of Medicine. He completed general surgery and urology training at UCSF, where he also completed fellowships in urologic oncology and minimally invasive surgery. Dr. Meng is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Meng is board certified in American Board Of Urology, Urology. Dr. Meng is currently accepting new patients.
Endocrine Surgery And Oncology Clinic
Dr. Julie Ann Sosa is an endocrine surgeon who specializes in thyroid cancer. She also has expertise in treating adults and children for a variety of benign and malignant endocrine conditions of the thyroid, parathyroid and adrenal glands. She chairs the UCSF Department of Surgery. Sosa's research focuses on developing treatments for advanced thyroid cancer and understanding environmental factors that can raise a person's risk for the disease. She also has published extensively on predictors of optimal patient outcomes following a variety of cancer-based procedures. Sosa earned her medical degree at Johns Hopkins University School of Medicine, where she also completed the Halsted residency in general surgery and served as chief resident. She completed a fellowship in clinical research with the Robert Wood Johnson Foundation at Johns Hopkins, where she was also assistant chief of service and an instructor. She has a master's degree in human sciences from the University of Oxford. Prior to joining UCSF, she was chief of endocrine surgery at Duke University, and held leadership positions at the Duke Cancer Institute and Duke Clinical Research Institute. Sosa is a fellow of the American College of Surgeons. She is the elected editor-in-chief of the World Journal of Surgery, and had previous positions as deputy editor of JAMA Surgery and associate editor of the Journal of Surgical Research. She serves on the editorial boards of seven medical journals, including the Annals of Surgery, Surgery, Annals of Surgical Oncology, Endocrine and International Journal of Endocrine Oncology. She serves on the boards of the Society of Surgical Oncology, International Thyroid Oncology Group, Association for Academic Surgery Foundation and American Thyroid Association, where she is also treasurer. She is the Leon Goldman, MD Distinguished Professor of Surgery at UCSF. Sosa was born in Montréal and raised in upstate New York. Dr. Sosa is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Papillary Thyroid Cancer, Parathyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Sosa is board certified in American Board Of Surgery, General Surgery. Dr. Sosa is currently accepting new patients.
Head And Neck Medical Oncology Program
Dr. Alain Algazi is a specialist in medical treatment – such as chemotherapy and immunotherapy – for patients with head and neck cancers, including head and neck squamous cell carcinoma, thyroid cancers and salivary gland cancers. He leads UCSF's program in medical therapy for head and neck cancers, and chairs the head and neck cancer research committee. In research, Algazi conducts clinical trials – studies that evaluate new therapies for head and neck cancers with an emphasis on approaches to improving the chances of long term remission in patients with incurable cancer using immunotherapy. He has also served the national study chair for clinical trials that give patients access to new medications and that provide new approaches of administering existing medications to improve their efficacy. Algazi earned his medical degree from the David Geffen School of Medicine at UCLA and completed a residency in internal medicine at Ronald Reagan UCLA Medical Center. He completed a fellowship in hematology-oncology at UCSF. Algazi is a member of the American Society of Clinical Oncology, Society for Immunotherapy for Cancer and American Association for Cancer Research. To reach Dr. Alain Algazi, please contact the head and neck medical oncology practice at (415) 353-9900. Dr. Algazi is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, and Glioma. Dr. Algazi is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Algazi is currently accepting new patients.
Prostate Cancer Center
Dr. Sima Porten is a specialist in cancers of the genital and urinary organs. She is a member of the urologic oncology team at the UCSF Helen Diller Family Comprehensive Cancer Center. Her clinical interests include the diagnosis and treatment of genitourinary cancer, particularly bladder cancer, upper tract urothelial cancer, kidney cancer and high-risk prostate cancer. Porten's research focuses mainly on the diagnosis and management of urothelial carcinoma, a cancer involving parts of the kidney, bladder and ureter (the tube connecting each kidney to the bladder). In studying the biologic or genetic basis of urothelial carcinoma, she hopes to develop new tests and treatments to bring personalized medicine to patients with bladder cancer. Porten received her undergraduate, medical and master of public health degrees from Northwestern University. During medical school, she was inducted into the Alpha Omega Alpha Honor Medical Society and also completed a fellowship through the Howard Hughes Medical Institute–National Institutes of Health Research Scholars Program. She then completed her urology residency training at UCSF, where she received the Julius R. Krevans Award for Clinical Excellence. During her training in urologic oncology at the University of Texas MD Anderson Cancer Center, she was awarded a John Quale Travel Fellowship for her research in bladder cancer. Porten is an active member of the American Urological Association, American Society of Clinical Oncology, Society of Women in Urology and Society of Urologic Oncology. Dr. Porten is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Porten is board certified in American Board Of Urology, Urology. Dr. Porten is currently accepting new patients.
Frequently Asked Questions about Dr. Madhulika (. Varma
How do I make an appointment with Dr. Madhulika (. Varma?
You can book an appointment with Dr. Madhulika (. Varma by calling their office at 415-885-3606. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Madhulika (. Varma a top-rated expert for Familial Colorectal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Madhulika (. Varma is classified as an Distinguished expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Madhulika (. Varma specialize in?
While Dr. Madhulika (. Varma is a Oncology, they have specific expertise in Familial Colorectal Cancer, Crohn's Disease, and Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Madhulika (. Varma participate in research or clinical trials?
Yes. Dr. Madhulika (. Varma has published 52 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Dr. Madhulika (. Varma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Madhulika (. Varma accept my insurance?
Dr. Madhulika (. Varma accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 415-885-3606 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Colorectal CancerDr. Varma isDistinguished. Learn about Familial Colorectal Cancer.
- Advanced
- Bladder ReconstructionDr. Varma isAdvanced. Learn about Bladder Reconstruction.
- Colorectal CancerDr. Varma isAdvanced. Learn about Colorectal Cancer.
- Crohn's DiseaseDr. Varma isAdvanced. Learn about Crohn's Disease.
- Hernia SurgeryDr. Varma isAdvanced. Learn about Hernia Surgery.
- Lynch SyndromeDr. Varma isAdvanced. Learn about Lynch Syndrome.
- Experienced
- Anal CancerDr. Varma isExperienced. Learn about Anal Cancer.
- Appendix CancerDr. Varma isExperienced. Learn about Appendix Cancer.
- Gastroesophageal Junction CancerDr. Varma isExperienced. Learn about Gastroesophageal Junction Cancer.
- Neuroendocrine TumorDr. Varma isExperienced. Learn about Neuroendocrine Tumor.
- Neurogenic BowelDr. Varma isExperienced. Learn about Neurogenic Bowel.
- Reconstructive Urology SurgeryDr. Varma isExperienced. Learn about Reconstructive Urology Surgery.
- Squamous Cell Carcinoma of the Anal Canal (SCAC)
- Ulcerative ColitisDr. Varma isExperienced. Learn about Ulcerative Colitis.





